BioCryst Pharmaceuticals (BCRX) Fails to deliver data

Key failure to deliver metrics for BioCryst Pharmaceuticals :

• Last SEC data release: 2026-05-29
• Last 15 days FTD volume: $1.53 M
• Last 3 months FTD volume: $5.12 M
• Last 12 months FTD volume: $7.68 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for BioCryst Pharmaceuticals (BCRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for BioCryst Pharmaceuticals (BCRX) - since 2013

BioCryst Pharmaceuticals (BCRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Gilead Sciences GILD	$14.61 M	$0.12 B	🇺🇸 USA
GSK plc GSK	$54.36 M	$0.23 B	🇬🇧 UK
Sarepta Therapeutics SRPT	$11.5 M	$25.12 M	🇺🇸 USA
Repligen RGEN	$22.72 M	$34.66 M	🇺🇸 USA
Novavax NVAX	$16.14 M	$60.86 M	🇺🇸 USA
Celldex Therapeutics CLDX	$0.85 M	$11.08 M	🇺🇸 USA
NanoViricides NNVC	$1.05 M	$5.04 M	🇺🇸 USA
Cel-Sci CVM	$0.71 M	$6.15 M	🇺🇸 USA
Emergent BioSolutions EBS	$0.34 M	$3.45 M	🇺🇸 USA